HARRIS & HARRIS GROUP INC /NY/
10-Q, 1998-05-15
Previous: PIPER INSTITUTIONAL FUNDS INC, NSAR-A, 1998-05-15
Next: TECHNOLOGY FUNDING MEDICAL PARTNERS I L P, 10-Q, 1998-05-15




 
                                     UNITED STATES
                           SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D. C.  20549

                                         Form 10-Q

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES 
EXCHANGE ACT OF 1934

           For quarterly period ended March 31, 1998

[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
EXCHANGE ACT OF 1934

           For the transition period from _______________ to ________________


                             Commission File Number: 0-11576


                               HARRIS & HARRIS GROUP, INC.
 -----------------------------------------------------------------------------
                  (Exact name of registrant as specified in its charter)
           
               New York                              13-3119827
- -------------------------------------      ------------------------------------
  (State or other jurisdiction of          (I.R.S. Employer Identification No.)
  incorporation or organization)                                       

One Rockefeller Plaza, Rockefeller Center, New York, New York       10020 
- ------------------------------------------------------------------------------
      (Address of Principal Executive Offices)                    (Zip Code)

                                      212/332-3600
- ------------------------------------------------------------------------------
                     (Registrant's telephone number, including area code)

  
    Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.                      

                              Yes __X__      No ____

    

<PAGE>

                             Harris & Harris Group, Inc.
                              Form 10-Q, March 31, 1998

                                 TABLE OF CONTENTS

                                                           Page Number
PART I. FINANCIAL INFORMATION

Item 1. Financial Statements . . . . . . . . . . . . . . .       1

Statements of Assets and Liabilities . . . . . . . . . . .       2

Statements of Operations . . . . . . . . . . . . . . . . .       3

Statements of Cash Flows . . . . . . . . . . . . . . . . .       4

Statements of Changes in Net Assets. . . . . . . . . . . .       5

Schedule of Investments. . . . . . . . . . . . . . . . . .       6

Notes to Financial Statements. . . . . . . . . . . . . . .      14

Item 2.  Management's Discussion and Analysis of 
Financial Condition and Results of Operations

Financial Condition. . . . . . . . . . . . . . . . . . . .      21

Results of Operations. . . . . . . . . . . . . . . . . . .      23

Liquidity and Capital Resources. . . . . . . . . . . . . .      24

Risks. . . . . . . . . . . . . . . . . . . . . . . . . . .      28

Item 3.  Quantitative and Qualitative Disclosures 
About Market Risk. . . . . . . . . . . . . . . . . . . . .      29

PART II  OTHER INFORMATION

Item 1.  Legal Proceedings . . . . . . . . . . . . . . . .      30
Item 2.  Changes in Securities . . . . . . . . . . . . . .      30
Item 3.  Defaults Upon Senior Securities . . . . . . . . .      30
Item 4.  Submission of Matters to a Vote of Security 
           Holders . . . . . . . . . . . . . . . . . . . .      30
Item 5.  Other Information . . . . . . . . . . . . . . . .      30
Item 6.  Exhibits and Reports on Form 8-K. . . . . . . . .      30   

Exhibit Index. . . . . . . . . . . . . . . . . . . . . . .      31
Signature. . . . . . . . . . . . . . . . . . . . . . . . .      32

                        Harris & Harris Group, Inc.
                         Form 10-Q, March 31, 1998


PART I.  FINANCIAL INFORMATION

Item 1. Financial Statements

      The information furnished in the accompanying financial statements 
reflects all adjustments that are, in the opinion of management, necessary 
for a fair presentation of the results for the interim period presented.

      On June 30, 1994, the Company's shareholders approved a proposal to 
allow the Company to make an election to become a Business Development 
Company ("BDC") under the Investment Company Act of 1940, as amended.  
The Company made such election on July 26, 1995.  Certain information and 
disclosures normally included in the financial statements in accordance with 
Generally Accepted Accounting Principles have been condensed or omitted as 
permitted by Regulation S-X and Regulation S-K. It is suggested that the 
accompanying financial statements be read in conjunction with the audited 
financial statements and notes thereto for the year ended December 31, 1997 
contained in the Company's 1997 Annual Report.

      On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification of the Company in 1998 as a Regulated 
Investment Company ("RIC") under Sub-Chapter M of the Internal Revenue  
(the "Code").  (At that time, the Company was taxable under Sub-Chapter C of 
the Code (a "C Corporation").)  On April 8, 1998, the Company announced that 
it had received a certification from the Securities and Exchange Commission 
for 1997 relating to the Company's status under section 851(e) of the Code.  
That certification was necessary for the Company to qualify as a RIC for 
1998 and subsequent taxable years.

      Pursuant to the Company's receipt of the section 851(e) certification, 
the Company's Board of Directors declared a one-time cash dividend of $0.75 
per share to meet one of the Company's requirements for qualification for 
Sub-Chapter M tax treatment in 1998.  The Company has requested rulings from 
the Internal Revenue Service (the "IRS") regarding other issues relevant to 
the Company's tax status as a RIC.  (See Note 5 of Notes to Financial 
Statements.) Although there is no assurance such rulings will be issued, the 
management of the Company believes favorable rulings are likely.

      The qualification of the Company as a RIC under Sub-Chapter M of the 
Code depends on it satisfying certain technical requirements regarding its 
income, investment portfolio, and distributions.  (See "Management's 
Discussion and Analysis of Financial Condition and Results of Operations - 
Recent Developments".)  There can be no assurance that the Company will 
qualify for Sub-Chapter M treatment for 1998 or subsequent years.  
Nevertheless, the Company's financial statements for 1998 assume that the 
Company will qualify for such treatment and that the rulings requested from 
the IRS will be issued.
                                     1
<TABLE>
<CAPTION>
                     STATEMENTS OF ASSETS AND LIABILITIES
                                     
                                    ASSETS

<S>                                        <C>              <C>           
                                           March 31, 1998   December 31, 1997
                                              (Unaudited)           (Audited)
                                                              
Investments, at value (See accompanying 
schedule of investments and notes). . . .   $  35,676,498       $  38,659,230
Cash and cash equivalents . . . . . . . .         163,534             145,588
Prepaid expenses. . . . . . . . . . . . .         112,353              85,126
Other assets. . . . . . . . . . . . . . .         215,273             383,840
                                            -------------       -------------
Total assets. . . . . . . . . . . . . . .   $  36,167,658       $  39,273,784
                                            =============       =============

                           LIABILITIES & NET ASSETS

Accounts payable and accrued liabilities.   $     814,923       $     899,491
Deferred rent . . . . . . . . . . . . . .          49,349              51,662
Deferred income tax liability (Note 5). .         151,983             667,697
Note Payable (Note 6) . . . . . . . . . .       1,500,000           4,000,000
                                            -------------       -------------   
Total liabilities . . . . . . . . . . . .       2,516,255           5,618,850
Commitments and contingencies (Note 6)      -------------       -------------

Net assets. . . . . . . . . . . . . . . .   $  33,651,403       $  33,654,934
                                            -------------       -------------
Net assets are comprised of:
Preferred stock, $0.10 par value, 
   2,000,000 shares authorized; 
   none issued. . . . . . . . . . . . . .   $           0       $           0
Common stock, $0.01 par value, 25,000,000 
   shares authorized; 10,692,971 issued 
   and outstanding at 3/31/98 and 
   12/31/97 . . . . . . . . . . . . . . .         106,930             106,930
Additional paid in capital. . . . . . . .      16,178,979          16,178,979
Accumulated net realized income . . . . .      11,552,730          12,028,191
Accumulated unrealized appreciation of 
   investments, net of deferred tax 
   liability of $2,008,941 at 3/31/98 
   and $2,817,898 at 12/31/97 . . . . . .       5,812,764           5,340,834
                                            -------------       -------------
Net assets. . . . . . . . . . . . . . . .   $  33,651,403       $  33,654,934
                                            -------------       -------------
Total net assets and liabilities. . . . .   $  36,167,658       $  39,273,784
                                            =============       =============
Shares outstanding. . . . . . . . . . . .      10,692,971          10,692,971
                                            -------------       ------------- 
Net asset value per outstanding share . .   $        3.15       $        3.15
                                            =============       =============
 
 The accompanying notes are an integral part of these financial statements.
</TABLE>
                                    2
<TABLE>
<CAPTION>
                        STATEMENTS OF OPERATIONS
                               (Unaudited)


<S>                               <C>                  <C>
                                  Three Months Ended   Three Months Ended
                                      March 31, 1998       March 31, 1997
Investment income:
  Interest from:
    Fixed-income securities. . . . .   $     192,291        $     136,287
    Affiliated companies . . . . . .          10,932               10,000
    Other income . . . . . . . . . .           7,348                  869
                                       -------------        -------------
    Total investment income. . . . .         210,571              147,156

Expenses:
  Salaries and benefits. . . . . . .          37,848              440,324
  Administration and operations. . .          88,204               98,327
  Professional fees. . . . . . . . .          89,026               88,097
  Depreciation . . . . . . . . . . .          12,500               15,000
  Rent . . . . . . . . . . . . . . .          38,808               39,497
  Directors' fees and expenses . . .          28,742               35,848
  Custodian fees . . . . . . . . . .           2,907                3,506
  Interest expense (Note 6). . . . .          73,415                    0 
                                       -------------        -------------
  Total expenses . . . . . . . . . .         371,450              720,599
  Operating loss before income 
    taxes. . . . . . . . . . . . . .       (160,879)            (573,443)
  Income tax (provision) benefit 
    (Note 5) . . . . . . . . . . . .       (365,712)              198,881
                                       -------------        -------------
Net operating loss . . . . . . . . .       (526,591)            (374,562)


Net realized gain on investments:
  Realized gain on sale of 
    investments. . . . . . . . . . .          78,661              623,108
                                       -------------        -------------
    Total realized gain. . . . . . .          78,661              623,108
  Income tax provision (Note 5). . .        (27,531)            (218,088)
                                       -------------        -------------
  Net realized gain on investments .          51,130              405,020
                                       -------------        -------------
Net realized (loss) income . . . . .       (475,461)               30,458

Net increase (decrease) in unrealized appreciation on investments:
  Decrease as a result of investment
    sales. . . . . . . . . . . . . .        (87,898)          (1,764,909)
  Increase on investments held . . .       3,825,792            1,414,354
  Decrease on investments held . . .     (4,074,921)          (2,253,670)
                                       -------------        -------------
    Change in unrealized appreciation 
    on investments . . . . . . . . .       (337,027)          (2,604,225)
  Income tax benefit (Note 5). . . .         808,957              911,479
                                       -------------        -------------
  Net increase (decrease) in unrealized 
    appreciation on investments. . .         471,930          (1,692,746)
                                       -------------        -------------
Net decrease in net assets from operations:
  Total. . . . . . . . . . . . . . .   $     (3,531)        $ (1,662,288)
                                       =============        =============
  Per outstanding share. . . . . . .   $      (0.00)           $   (0.16)
                                       =============        =============

The accompanying notes are an integral part of these financial statements.
</TABLE>
                                   3
<TABLE>
<CAPTION>
                           STATEMENTS OF CASH FLOWS
                                 (Unaudited)

<S>                                   <C>                 <C>
                                      Three Months Ended  Three Months Ended
                                          March 31, 1998      March 31, 1997

Cash flows (used in) provided by operating activities:
Net decrease in net assets 
 resulting from operations . . . . . .     $     (3,531)       $ (1,662,288)
Adjustments to reconcile net decrease 
in net assets from operations to net 
cash (used in) provided by operating 
activities:
 Net realized and unrealized loss (gain)
   on investments. . . . . . . . . . .           258,366           1,981,117
 Deferred income taxes . . . . . . . .         (415,714)           (908,469)
 Depreciation. . . . . . . . . . . . .            12,500              15,000

Changes in assets and liabilities:
 Receivable from brokers . . . . . . .                 0            (25,374)
 Prepaid expenses. . . . . . . . . . .          (27,227)              20,976
 Taxes receivable. . . . . . . . . . .                 0              16,197
 Other assets. . . . . . . . . . . . .           156,067             224,586
 Accounts payable and accrued 
   liabilities . . . . . . . . . . . .         (215,719)            (28,297)
 Payable to brokers. . . . . . . . . .                 0             411,354
 Deferred rent . . . . . . . . . . . .           (2,313)             (2,313)
 Purchase of fixed assets. . . . . . .                 0             (2,847)
                                           -------------       -------------   
 Net cash (used in) provided by 
   operating activities. . . . . . . .         (237,571)              39,642

Cash provided by (used in) investing activities:
 Net sale of short-term investments
   and marketable securities . . . . .         2,877,319           1,709,625
 Investment in private placements 
   and loans . . . . . . . . . . . . .         (121,802)         (1,745,585)
                                           -------------       -------------
 Net cash provided by (used in) 
   investing activities. . . . . . . .         2,755,517            (35,960)

Cash flows used in financing activities:
 Payment of note payable (Note 6). . .       (2,500,000)                   0
                                           -------------       -------------
 Net cash used in financing activities       (2,500,000)                   0

Net increase in cash and cash equivalents:
 Cash and cash equivalents at beginning 
   of the period . . . . . . . . . . .           145,588             155,440
 Cash and cash equivalents at end of 
   the period. . . . . . . . . . . . .           163,534             159,122
                                           -------------       -------------
 Net increase in cash and cash equivalents $      17,946       $       3,682
                                           =============       =============
Supplemental disclosures of cash flow information:
 Income taxes paid . . . . . . . . . .     $         300       $       5,909
 Interest paid . . . . . . . . . . . .     $      44,180       $           0

  The accompanying notes are an integral part of these financial statements.
</TABLE>
                                       4
<TABLE>
<CAPTION>
                      STATEMENTS OF CHANGES IN NET ASSETS 
                                 (Unaudited)

<S>                                  <C>                 <C>
                                     Three Months Ended  Three Months Ended
                                         March 31, 1998      March 31, 1997

Changes in net assets from operations:

   Net operating loss. . . . . . . .      $   (526,591)       $   (374,562)
   Net realized gain on investments.             51,130             405,020
   Net decrease in unrealized 
     appreciation on investments as 
     a result of sales . . . . . . .           (87,898)         (1,147,190)
   Net increase (decrease) in 
     unrealized appreciation on 
     investments held. . . . . . . .            559,828           (545,556)
                                          -------------       -------------
   Net decrease in net assets resulting
     from operations . . . . . . . .            (3,531)         (1,662,288)
                                          -------------       -------------

Net decrease in net assets . . . . .            (3,531)         (1,662,288)

Net assets:

   Beginning of the period . . . . .         33,654,934          35,932,603
                                          -------------       -------------
   End of the period . . . . . . . .      $  33,651,403       $  34,270,315
                                          =============       =============
  The accompanying notes are an integral part of these financial statements.
</TABLE>
                                   5
<TABLE>
<CAPTION>                
                        SCHEDULE OF INVESTMENTS MARCH 31, 1998
                                   (Unaudited)

<S>                               <C>               <C>               <C>
                                      Method of       Shares/
                                  Valuation (3)     Principal         Value

Investments in Unaffiliated Companies (12)(13)(14) 
- -- 16.0% of total investments

Publicly Traded Portfolio (Common stock unless 
noted otherwise) -- 13.4% of total investments

 Oil and Gas Related
  CORDEX Petroleums Inc. (1)
    Argentine and Chilean oil and 
    gas exploration
    Class A Common Stock . . . . . . . . .(C)      4,052,080     $   145,342

 Biotechnology and Healthcare Related 
  Alliance Pharmaceutical Corp. (1)(4) . .(C)         57,500         434,843
  Fuisz Technologies, Ltd. (1) . . . . . .(C)        125,000       1,554,688
  Guilford Pharmaceuticals Inc. (1). . . .(C)         10,000         220,000

 Energy Research Corporation (1) -- 
  Fuel cell energy . . . . . . . . . . . .(C)         55,000       1,471,250

 Princeton Video Image, Inc. (1)(2)(7) 
  -- Real time sports and entertainment 
  advertising -- 1.4% of fully diluted 
  equity . . . . . . . . . . . . . . . . .(C)        150,200         966,536
                                                                  ----------
Total Publicly Traded Portfolio 
(cost: $3,579,097) . . . . . . . . . . . . . . . . . . . . . . .  $4,792,659


Private Placement Portfolio (Illiquid) -- 
2.6% of total investments

 Exponential Business Development 
  Company (1)(2)(5) -- Venture capital 
  partnership focused on early stage companies
  Limited partnership interest . . . . . .(A)           --        $   25,000

 MedLogic Global Corporation (1)(2) -- 
  Medical cyanoacrylate adhesive -- 
  0.51% of fully diluted equity
  Series B Convertible Preferred Stock . .(A)         60,319
  Common Stock . . . . . . . . . . . . . .(D)         25,798         891,700
                                                                  ----------
Total Private Placement Portfolio (cost: $1,058,775) . . . . . .  $  916,700
                                                                  ----------
Total Investments in 
 Unaffiliated Companies (cost: $4,637,872) . . . . . . . . . . .  $5,709,359

        The accompanying notes are an integral part of this schedule.
</TABLE>
                                      6

<TABLE>
<CAPTION>
                     SCHEDULE OF INVESTMENTS MARCH 31, 1998
                                 (Unaudited)

<S>                               <C>               <C>               <C>
                                      Method of       Shares/
                                  Valuation (3)     Principal         Value  

Investments in Non-Controlled Affiliates (12)(14) 
- -- 40.6% of total investments

Publicly Traded Portfolio -- 8.6% of total investments

 Nanophase Technologies Corporation 
  (1)(2)(6)(8) -- Manufactures and 
  markets inorganic crystals of 
  nanometric dimensions -- 5.08% of
  fully diluted equity Common Stock. . . .(C)         730,916    $3,051,400  
                                                                 ----------
Total Publicly Traded Portfolio (cost: $1,626,204) . . . . . . . $3,051,400

Private Placement Portfolio (Illiquid) -- 
32.0% of total investments 
  
 Genomica Corporation (1)(2)(5)(6)(9) 
  -- Develops software that enables 
  the study of complex genetic diseases -- 
  10.7% of fully diluted equity 
  Common Stock . . . . . . . . . . . . . .(A)         199,800
  Series A Voting Convertible Preferred 
  Stock. . . . . . . . . . . . . . . . . .(A)       1,660,200    $1,000,304

 NBX Corporation (1)(2)(6)(10) -- 
  Exploits innovative distributed 
  computing technology for use in small 
  business telephone systems -- 14.8% of
  fully diluted equity Series A 
  Convertible Preferred Stock. . . . . . .(B)         500,000               
  Series C Convertible Preferred Stock . .(B)         240,793                  
  Series D Convertible Preferred Stock . .(A)          59,965     4,540,298
  Promissory Note -- 8% due March 16, 
  2001 . . . . . . . . . . . . . . . . . .(A)     $    10,000        10,000

 PHZ Capital Partners Limited Partnership 
  (2) -- Organizes and manages investment 
  partnerships -- 20.0% of fully diluted 
  equity 
  Limited partnership interest . . . . . .(D)            --       1,405,622
  Demand Promissory Note -- 8% . . . . . .(A)     $   500,000       500,000

 PureSpeech, Inc. (1)(2)(6) -- Develops 
  and markets innovative speech 
  recognition technology -- 8.0% of 
  fully diluted equity
  Series A Convertible Preferred Stock . .(D)         190,476                 
  Convertible Promissory Note. . . . . . .(D)     $   243,980     1,713,370

 Questech Corporation (1)(2)(6) -- 
  Manufactures and markets proprietary 
  decorative tiles and signs -- 15.1% of 
  fully diluted equity
  Common Stock . . . . . . . . . . . . . .(D)         565,792     2,263,168
  Warrants at $4.00 expiring 11/28/01. . .(A)         166,667           167
                                                                -----------
Total Private Placement Portfolio (cost: $7,247,240). . . . . . $11,432,929
                                                                -----------
Total Investments in Non-Controlled Affiliates 
(cost: $8,873,444). . . . . . . . . . . . . . . . . . . . . . . $14,484,329

     The accompanying notes are an integral part of this schedule.
</TABLE>
                                    7
<TABLE>
<CAPTION>
                   SCHEDULE OF INVESTMENTS MARCH 31, 1998
                                (Unaudited)

<S>                               <C>               <C>              <C>
                                      Method of       Shares/
                                  Valuation (3)     Principal        Value

Private Placement Portfolio in 
Controlled Affiliates (12)(14) (Illiquid) 
- -- 10.5% of total investments

 BioSupplyNet, Inc. (1)(2)(6)(11) -- 
  Expands commercially the print 
  and World Wide Web product directories
  developed by Cold Spring Harbor 
  Laboratory Press -- 44.4% fully 
  diluted equity
  Series A Convertible Preferred Stock . .(A)         775,000   $   775,000
  Revolving Credit Facility (Note 6) . . .(A)     $   110,000       110,000  

 MultiTarget, Inc. (1)(2)(6) -- 
  Developing intellectual property
  related to localized treatment of cancer --
  37.5% of fully diluted equity
  Series A Convertible Preferred Stock . .(A)         375,000       210,000

 NeuroMetrix, Inc. (1)(2)(6) -- Developing
  devices for: 1) diabetics to monitor 
  their blood glucose and 2) detection of 
  carpal tunnel syndrome -- 29.0% of 
  fully diluted equity
  Series A Convertible Preferred Stock . .(B)         175,000
  Series B Convertible Preferred Stock . .(B)         125,000 
  Series C Convertible Preferred Stock . .(A)         229,620     2,648,100
                                                                ----------- 
Total Private Placement Portfolio 
 in Controlled Affiliates (cost: $2,605,000) . . . . . . . . .  $ 3,743,100

U.S. Government Obligations -- 32.9% of total investments

 U.S. Treasury Bill dated 04/03/97 due date
   04/02/98 -- 5.2% yield. . . . . . . . .(K)     $   250,000       249,963
 U.S. Treasury Bill dated 10/23/97 due date
   04/23/98 -- 5.2% yield. . . . . . . . .(K)     $ 7,550,000     7,525,387
 U.S. Treasury Bill dated 12/04/97 due date
   06/04/98 -- 5.0% yield. . . . . . . . .(K)     $ 4,000,000     3,964,360
                                                                -----------
Total Investments in U.S. Government Obligations
(cost: $11,738,477) . . . . . . . . . . . . . . . . . . . . . . $11,739,710
                                                                -----------
Total Investments -- 100% (cost: $27,854,793) . . . . . . . . . $35,676,498
                                                                ===========
    The accompanying notes are an integral part of this schedule.
</TABLE>
                                   8

               SCHEDULE OF INVESTMENTS MARCH 31, 1998
                             (Unaudited)


Notes to Schedule of Investments

(1)  Represents a non-income producing security.  Equity investments that 
     have not paid dividends within the last twelve months are considered to 
     be non-income producing.
(2)  Legal restrictions on sale of investment.
(3)  See Footnote to Schedule of Investments for a description of the Method 
     of Valuation A to L.
(4)  These investments were made during 1998.  Accordingly, the amounts shown 
     on the schedule represent the gross additions in 1998.
(5)  No changes in valuation occurred in these investments during the three 
     months ended March 31, 1998.
(6)  These investments are development stage companies.  A development stage 
     company is defined as a company that is devoting substantially all of its
     efforts to establishing a new business, and either has not yet commenced 
     its planned principal operations or has commenced such operations but 
     has not realized significant revenue from them.
(7)  Formerly named Princeton Electronic Billboard, Inc.  As of March 31, 
     1998, the market price per share of Princeton Video Image, Inc. ("PVII")
     was $8.125.  As of May 8, 1998, the market price was $5.563 and the 
     Company valued its holding at $674,656.  The Company is subject to a 
     lock-up agreement on the stock, which expires December 16, 1998.
(8)  As of March 31, 1998, the market price per share of Nanophase 
     Technologies Corporation ("NANX") was $5.375.  As of May 8, 1998, the 
     market price per share was $7.00,and the Company valued its holding at 
     $4,054,757.  The Company is subject to a lock-up agreement on the stock,
     which expires on May 26, 1998.
(9)  Genomica Corporation was cofounded by the Company, Cold Spring Harbor
     Laboratory and Falcon Technology Partners, LP.  Mr. G. Morgan Browne 
     serves on the Board of Directors of the Company and is Administrative 
     Director of  Cold Spring Harbor Laboratory.
(10) Formerly named PowerVoice Technologies, Inc.
(11) BioSupplyNet, Inc. was cofounded by the Company, Cold Spring Harbor 
     Laboratory and other investors.  Mr. G. Morgan Browne serves on the 
     Board of Directors and is Administrative Director of Cold Spring Harbor
     Laboratory.
(12) Investments in unaffiliated companies consist of investments in which 
     Harris & Harris Group,Inc. (the "Company") owns less than 5 percent of
     the investee company. Investments in non-controlled affiliated companies
     consist of investments where the Company owns more than 5 percent but 
     less than 25 percent of the investee company.  Investments in controlled
     affiliated companies consist of investments where the Company owns more 
     than 25 percent of the investee company.
(13) The aggregate cost for federal income tax purposes of investments in
     unaffiliated companies is $4,745,549.  The gross unrealized 
     appreciation based on tax cost for these securities is $1,569,243.  
     The gross unrealized depreciation based on the tax cost for these 
     securities is $605,433.
(14) The percentage ownership of each investee company disclosed in the 
     Schedule of Investments expresses the potential common equity interest 
     in each such investee.  The calculated percentage represents the amount 
     of the issuer's common stock the Company owns or can acquire as a 
     percentage of the issuer's total outstanding common stock plus common 
     shares reserved for issued and outstanding warrants, convertible 
     securities and stock options.

       The accompanying notes are an integral part of this schedule.

                                      9

                      FOOTNOTE TO SCHEDULE OF INVESTMENTS


ASSET VALUATION POLICY GUIDELINES

   The Company's investments can be classified into five broad categories for
valuation purposes:

     1) EQUITY-RELATED SECURITIES

     2) INVESTMENTS IN INTELLECTUAL PROPERTY OR PATENTS OR RESEARCH
        AND DEVELOPMENT IN TECHNOLOGY OR PRODUCT DEVELOPMENT

     3) LONG-TERM FIXED-INCOME SECURITIES
     4) SHORT-TERM FIXED-INCOME INVESTMENTS
     5) ALL OTHER INVESTMENTS

     The Investment Company Act of 1940 (the "1940 Act") requires periodic
valuation of each investment in the Company's portfolio to determine net asset
value. Under the 1940 Act, unrestricted securities with readily available 
market quotations are to be valued at the current market value; all other 
assets must be valued at "fair value" as determined in good faith by or 
under the direction of the Board of Directors.

     The Company's Board of Directors is responsible for 1) determining 
overall valuation guidelines and 2) ensuring the valuation of investments 
within the prescribed guidelines.

     The Company's Investment and Valuation Committee, comprised of at least 
three or more Board members, is responsible for reviewing and approving the 
valuation of the Company's assets within the guidelines established by the 
Board of Directors.

     Fair value is generally defined as the amount that an investment could 
be sold for in an orderly disposition over a reasonable time.  Generally, to 
increase objectivity in valuing the assets of the Company, external measures 
of value, such as public markets or third-party transactions, are utilized 
whenever possible.  Valuation is not based on long-term work-out value, nor 
immediate liquidation value, nor incremental value for potential changes 
that may take place in the future.

     Valuation assumes that, in the ordinary course of its business, the 
Company will eventually sell its investment.

     The Company's valuation policy with respect to the five broad investment
categories is as follows:

                                   10
EQUITY-RELATED SECURITIES

     Equity-related securities are carried at fair value using one or more 
of the following basic methods of valuation:

   A.  Cost:  The cost method is based on the original cost to the Company.  
This method is generally used in the early stages of a company's development 
until significant positive or negative events occur subsequent to the date 
of the original investment that dictate a change to another valuation method.
Some examples of such events are: 1) a major recapitalization; 2) a major 
refinancing; 3) a significant third-party transaction; 4) the development of 
a meaningful public market for the company's common stock; 5) significant 
positive or negative changes in the company's business.

   B.  Private Market:  The private market method uses actual third-party
transactions in the company's securities as a basis for valuation, using 
actual, executed, historical transactions in the company's securities by 
responsible third parties.  The private market method may also use, where 
applicable, unconditional firm offers by responsible third parties as a 
basis for valuation.

   C.  Public Market:   The public market method is used when there is an
established public market for the class of the company's securities held by 
the Company.  The Company discounts market value for securities that are 
subject to significant legal, contractual or practical restrictions, 
including large blocks in relation to trading volume.  Other securities, for
which market quotations are readily available, are carried at market value 
as of the time of valuation.

     Market value for securities traded on securities exchanges or on the 
Nasdaq National Market is the last reported sales price on the day of 
valuation.  For other securities traded in the over-the-counter market and 
listed securities for which no sale was reported on that day, market value 
is the mean of the closing bid price and asked price on that day.

     This method is the preferred method of valuation when there is an 
established public market for a company's securities, as that market 
provides the most objective basis for valuation.

   D.  Analytical Method:  The analytical method is generally used to value 
an investment position when there is no established public or private market 
in the company's securities or when the factual information available to the 
Company dictates that an investment should no longer be valued under either 
the cost or private market method. This valuation method is inherently 
imprecise and ultimately the result of reconciling the judgments of the 
Company's Investment and Valuation Committee members, based on the data 
available to them. The resulting valuation, although stated as a precise 
number, is necessarily within a range of values that vary depending upon the 
significance attributed to the various factors being considered. Some of the 
factors considered may include the financial condition and operating results 
of the company, the long-term potential of the business of the company, the 
values of similar securities issued by companies in similar businesses, the 

                                11

proportion of the company's securities owned by the Company and the nature 
of any rights to require the company to register restricted securities under
applicable securities laws.

INVESTMENTS IN INTELLECTUAL PROPERTY OR PATENTS OR RESEARCH AND DEVELOPMENT 
IN TECHNOLOGY OR PRODUCT DEVELOPMENT

  Such investments are carried at fair value using the following basic 
methods of valuation:

  E.  Cost:  The cost method is based on the original cost to the Company. 
Such method is generally used in the early stages of commercializing or 
developing intellectual property or patents or research and development in 
technology or product development until significant positive or adverse events 
occur subsequent to the date of the original investment that dictate a change 
to another valuation method.

  F.  Private Market:  The private market method uses actual third-party
investments in intellectual property or patents or research and development
in technology or product development as a basis for valuation, using actual 
executed historical transactions by responsible third parties.  The private 
market method may also use, where applicable, unconditional firm offers by 
responsible third parties as a basis for valuation.

  G.  Analytical Method:  The analytical method is used to value an investment
after analysis of the best available outside information where the factual
information available to the Company dictates that an investment should no 
longer be valued under either the cost or private market method. This 
valuation method is inherently imprecise and ultimately the result of 
reconciling the judgments of the Company's Investment and Valuation Committee 
members. The resulting valuation, although stated as a precise number, is 
necessarily within a range of values that vary depending upon the 
significance attributed to the various factors being considered. Some of the 
factors considered may include the results of research and development, 
product development progress, commercial prospects, term of patent and
projected markets.


LONG-TERM FIXED-INCOME SECURITIES

  H.  Fixed-Income Securities for which market quotations are readily 
available are carried at market value as of the time of valuation using the 
most recent bid quotations when available.

  Securities for which market quotations are not readily available are 
carried at fair value using one or more of the following basic methods of 
valuation:

  I.  Fixed-Income Securities  are valued by independent pricing services 
that provide market quotations based primarily on quotations from dealers 
and brokers, market transactions, and other sources.

                                      12

  J.  Other Fixed-Income Securities that are not readily marketable are 
valued at fair value by the Investment and Valuation Committee.

SHORT-TERM FIXED-INCOME INVESTMENTS

  K.  Short-Term Fixed-Income Investments are valued at market value at the 
time of valuation.  Short-term debt with remaining maturity of 60 days or 
less is valued at amortized cost.


ALL OTHER INVESTMENTS

  L.  All Other Investments are reported at fair value as determined in good
faith by the Investment and Valuation Committee.

  The reported values of securities for which market quotations are not 
readily available and for other assets reflect the Investment and Valuation 
Committee's judgment of fair values as of the valuation date using the 
outlined basic methods of valuation.  They do not necessarily represent an 
amount of money that would be realized if the securities had to be sold in an 
immediate liquidation.  The Company makes many of its portfolio investments 
with the view of holding them for a number of years, and the reported value of 
such investments may be considered in terms of disposition over a period of 
time. Thus valuations as of any particular date are not necessarily 
indicative of amounts that may ultimately be realized as a result of future 
sales or other dispositions of investments held.

                                    13

                       NOTES TO FINANCIAL STATEMENTS
                                (Unaudited)


NOTE 1.  THE COMPANY

     Harris & Harris Group, Inc. (the "Company") is a venture capital 
investment company operating as a business development company ("BDC") under 
the Investment Company Act of 1940 ("1940 Act").  The Company operates as an 
internally managed investment company whereby its officers and employees, 
under the general supervision of its Board of Directors, conduct its 
operations.

     The Company elected to become a BDC on July 26, 1995, after receiving 
the necessary approvals.  From September 30, 1992 until the election of BDC
status, the Company operated as a closed-end, non-diversified, investment 
company under the 1940 Act.  Upon commencement of operations as an investment
company, the Company revalued all of its assets and liabilities at fair value 
as defined in the 1940 Act.  Prior to such time, the Company was registered 
and filed under the reporting requirements of the Securities and Exchange 
Act of 1934 as an operating company and, while an operating company, 
operated directly and through subsidiaries.  As a BDC, the Company continues
to be subject to such reporting requirements.

     On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification in 1998 as a RIC under Sub-Chapter M of the 
Code.  As a RIC, the Company must, among other things, distribute at least 
90 percent of its taxable net income and may either distribute or retain its
taxable net realized capital gains on investments.  (See "Management's 
Discussion and Analysis of Financial Condition and Results of Operations 
- - Recent Developments.")  There can be no assurance that the Company will
qualify as a RIC or that if it does qualify, it will continue to qualify. 

NOTE 2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     The following is a summary of significant accounting policies followed 
in the preparation of the financial statements:

     Cash and Cash Equivalents.  Cash and cash equivalents include money 
market instruments with maturities of less than three months.

     Portfolio Investment Valuations.  Investments are stated at "fair value" 
as defined in the 1940 Act and in the applicable regulations of the Securities 
and Exchange Commission.  All assets are valued at fair value as determined in 
good faith by, or under the direction of, the Board of Directors. See the 
Asset Valuation Policy Guidelines in the Footnote to Schedule of Investments. 

     Securities Transactions.  Securities transactions are accounted for on 
the date the securities are purchased or sold (trade date); dividend income 
is recorded on the ex-dividend date; and interest income is accrued as earned.  
Realized gains and losses on investment transactions are determined on the 
first-in, first-out basis for financial reporting and tax bases.<PAGE>
    
   
                                    14

     Income Taxes.  Prior to January 1, 1998, the Company recorded income 
taxes using the liability method in accordance with the provision of Statement
of Financial Accounting Standards No. 109.  Accordingly, deferred tax 
liabilities had been established to reflect temporary differences between the
recognition of income and expenses for financial reporting and tax purposes, 
the most significant difference of which relates to the Company's unrealized
appreciation on investments.

     The March 31, 1998 financial statements do not include a provision for
deferred taxes on unrealized gains other than the provision for taxes on the
unrealized gains as of December 31, 1997, net of the operating and capital 
loss carryforwards incurred by the Company through December 31, 1997.  
(See Note 5. Income Taxes.)

     Reclassifications.  Certain reclassifications have been made to the 
December 31, 1997 financial statements to conform to the March 31, 1998 
presentation.

     Estimates by Management.  The preparation of the financial statements in
conformity with Generally Accepted Accounting Principles requires management to
make estimates and assumptions that affect the reported amounts of assets and 
liabilities as of March 31, 1998 and December 31,1997, and the reported amounts 
of revenues and expenses for the three months ended March 31, 1998 and 
March 31, 1997.  Actual results could differ from these estimates.


NOTE 3.  STOCK OPTION PLAN AND WARRANTS OUTSTANDING

     On August 3, 1989, the shareholders of the Company approved the 1988 Long 
Term Incentive Compensation Plan.  On June 30, 1994, the shareholders of the 
Company approved various amendments to the 1988 Long Term Incentive 
Compensation Plan: 1) to conform to the provisions of the Business Development 
Company regulations under the 1940 Act, which allow for the issuance of stock 
options to qualified participants; 2) to increase the reserved shares under the 
amended plan; 3) to call the plan the 1988 Stock Option Plan, as Amended and 
Restated (the "1988 Plan"); and 4) to make various other amendments.  On 
October 20, 1995, the shareholders of the Company approved an amendment to
the 1988 Plan authorizing automatic 20,000 share grants ofnon-qualified stock
options to newly elected non-employee directors of the Company.

     The Company's 1988 Plan was cancelled as of December 31, 1997, canceling
all outstanding stock options and eliminating all potential stock option 
grants.  As of January 1, 1998, the Company adopted the Harris & Harris Group, 
Inc. Employee Profit-Sharing Plan ("Plan") that provides for profit-sharing 
equal to 20 percent of net after-tax income, with the exception of unrealized 
gains as of September 30, 1997, on which gains the Company will not pay 
employee profit-sharing.  For the three months ended March 31, 1998, the 
Company had accrued $225,045 under the Plan.

                                        15

     The Company accounted for the 1988 Plan under APB Opinion No. 25, under
which no compensation cost has been recognized.  Had compensation cost for the 
1988 Plan been determined consistent with the fair value method required by 
FASB Statement No.123 ("FASB No. 123"), the Company's net realized (loss) 
income and net asset value per share would have been reduced to the 
following pro-forma amounts:  

<TABLE>
<S>                                       <C>
                                          March 31, 1997
Net Realized (Loss) Income:                       

As Reported                                      $30,458
Pro Forma                                     $(111,958)

Net Asset Value per share:                        

As Reported                                        $3.28
Pro Forma                                          $3.27
</TABLE>

      The fair value of each option grant is estimated on the date of
grant using the Black-Scholes option pricing model with the following weighted 
average assumptions:

<TABLE>
<S>                                       <C>
                                          March 31, 1997

    Stock volatility                           0.60
    Risk-free interest rate                    6.3% 
    Option term in years                         7
    Stock dividend yield                        - -
</TABLE>

      The FASB No. 123 method of accounting has not been applied to options 
granted prior to January 1, 1995.  

                                     16

      A summary of the status of the Company's 1988 Plan at March 31, 1997 and 
changes during the three months then ended is presented in the table and 
narrative below:
                                                                             
<TABLE>
<S>                          <C>              <C>              
                                     March 31, 1997
                             ---------------------------------
                                              Weighted Average
                                              ________________
                             Shares            Exercise Price
                               
Outstanding at
   beginning of period    1,080,000               $4.58

Granted                     300,000               $3.88

Exercised                     - -                   - -

Forfeited                   200,000               $5.37

Expired                       - -                  - -

Canceled                      - -                  - -

Outstanding at 
   end of period          1,180,000               $4.27

Exercisable at 
end of period               403,000               $3.42

Weighted average fair 
value of options granted      $2.50                - -
</TABLE>

NOTE 4.  EMPLOYEE BENEFITS

     The Company has an employment and severance contract ("Employment 
Contract") with its Chairman, Charles E. Harris, pursuant to which he is to
receive compensation in the form of salary and other benefits.  On January 1, 
1998 Mr. Harris' Employment Contract was amended to reduce his salary to 
$200,000 and to allow him to participate in other business opportunities and 
investments.  The term of the contract expires on December 31, 1999.  Base 
salary is to be increased annually to reflect inflation and in addition may be
increased by such amount as the Compensation Committee of the Board of 
Directors of the Company deems appropriate.  In addition, Mr. Harris would be 
entitled, under certain circumstances, to receive severance pay under the 
employment and severance contracts.

     As of January 1, 1989, the Company adopted an employee benefits program
covering substantially all employees of the Company under a 401(k) Plan and 
Trust Agreement.  The Company's contribution to the plan is determined by
the Compensation Committee in the fourth quarter.

     On June 30, 1994, the Company adopted a plan to provide medical and 
health coverage for retirees, their spouses and dependents who, at the time 
of their retirement, have ten years of service with the Company and have 
attained 50 years of age or have attained 45 years of age and have 15 years 
of service with the Company.  On February 10, 1997, the Company amended this
plan to include employees who "have seven full years of service and have 
attained 58 years of age."  The coverage is secondary to any government 
  
                                    17

provided or subsequent employer provided health insurance plans.  Based upon 
actuarial estimates, the Company provided an original reserve of $176,520 that
was charged to operations for the period ending June 30, 1994.  As of 
March 31, 1998, the Company had a reserve of $232,415 for the plan.

NOTE 5.  INCOME TAXES 
     
     For the three months ended March 31, 1998 and 1997, the Company's income 
tax benefit was allocated as follows:

<TABLE>
<S>                                  <C>                  <C>          
                                     Three Months Ended   Three Months Ended
                                       March 31, 1998       March 31, 1997

Investment operations                $      (365,712)      $      198,881
Realized (loss) gain on investments          (27,531)            (218,088)
Decrease in unrealized 
      appreciation on investments            808,957              911,479
                                     ----------------      --------------- 

Total income tax benefit             $       415,714       $      892,272
                                     ================      =============== 

The above tax benefit consists of the following:

Current -- Federal                   $       (100,000)     $      (16,197)
Deferred -- Federal                           515,714             908,469
                                     -----------------     ---------------

Total income tax benefit             $        415,714      $      892,272
                                     =================     =============== 
</TABLE>

    The Company's net deferred tax liability at March 31, 1998 and December
31, 1997 consists of the following:

<TABLE>
<S>                                        <C>             <C>
                                           March 31, 1998  December 31, 1997

Unrealized appreciation on investments        $ 2,008,941     $  2,817,898
Net operating loss and capital carryforward   (1,856,958)      (1,856,958)
Medical retirement benefits                       - -             (81,345)
Other                                             - -            (211,898)
                                             ------------    -------------

Net deferred income tax liability            $    151,983     $    667,697
                                             ============     =============
</TABLE>

     On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification in 1998 as a RIC under Sub-Chapter M of the
Code. As a RIC, the Company annually must distribute at least 90 percent of 
its investment company taxable income as a dividend and may either distribute 
or retain its taxable net capital gains from investments.  There can be no 
assurance that the Company will qualify as a RIC or that, if it does qualify, 
it will continue to qualify.  To initially qualify as a RIC, the Company must 
pay a dividend to shareholders equal to the Company's pre-RIC cumulative 
realized earnings and profits ("E&P").  On April 9, 1998, the Company
declared a one-time cash dividend of $0.75 per share to meet this requirement
(for a total of $8,019,728).  Continued qualification as a RIC requires the 
Company to satisfy certain portfolio diversification requirements in
future years.  The Company's ability to satisfy those requirements may
not be controllable by the Company.  (See "Management's Discussion and
Analysis of Financial Condition and Results of Operation - Recent 
Developments.")

     The Company incurred ordinary and capital losses for a total of 
approximately $5.3 million during its C Corporation taxable years that remain
available for use and may be carried forward to its 1998 and subsequent 
taxable years.  Ordinarily, a corporation that elects to qualify as a RIC 
may not use its loss carryforwards from C Corporation taxable years to offset
RIC investment company taxable income or net capital gains.  In addition, 
a corporation that elects to qualify as a RIC continues to be taxable as a C
Corporation on any gains realized within 10 years of its qualification as a
RIC from sales of assets that were held by the corporation on the effective
date of the election ("C Corporation Assets") to the extent of any gain built
into the assets on such date ("Built-In Gain").  The Company has filed a 
private ruling request with the Internal Revenue Service ("IRS") asking the 
IRS to rule that the Company can carry forward its C Corporation losses to 
offset any Built-In Gains resulting from sales of its C Corporation Assets,
thereby enabling the Company to retain some or all of the proceeds from 
such sales without disqualifying itself as a RIC or incurring corporate level 
income tax.  The Company intends to use the $5.3 million loss carryforward to 
reduce the taxes due to Built-In Gains.  The increase in NAV per share as a 
result of including the ordinary and capital loss carryforwards in the 
March 31, 1998 financial statements is approximately $0.17.

     In addition, because a RIC is not permitted to have, as of the close 
of any RIC taxable year, E&P accumulated during any C Corporation taxable year, 
the Company has also requested a ruling that its sale of C Corporation Assets
with Built-In Gains during RIC taxable years will not generate C Corporation 
E&P.  Although there is no guarantee that the IRS will rule favorably on the 
Company's request for rulings, the management of the Company believes that 
favorable rulings are likely.  

     The Company's net deferred income tax liability would have been
approximately $525,000 had it continued to account for its taxes as a C 
Corporation.
                                                      
NOTE 6.  COMMITMENTS AND CONTINGENCIES

     During 1993, the Company signed a ten-year lease with sublet 
provisions for office space.  In 1995, this lease was amended to include 
additional office space.  Rent expense under this lease for the three months 
ended March 31, 1998 and 1997, was $38,808 and $39,497, respectively.  Future 
minimum lease payments in each of the following years are: 1999 -- $176,030; 
2000 -- $178,561; 2001 -- $178,561; 2002 -- $178,561; 2003 -- $101,946. 
         
     In December 1993, the Company and MIT announced the establishment by
the Company of the Harris & Harris Group Senior Professorship at MIT.  Prior 
to the arrangement for the establishment of this Professorship, the Company 
had made gifts of stock in start-up companies to MIT.  These gifts, together 
with the contribution of $700,000 in cash in 1993, which was expensed by the 
Company in 1993, were used to establish this named chair.  The Company 
contributed to MIT securities with a cost basis of $3,280, $20,000 and 
$20,000 in 1993, 1994, and 1995, respectively.  These contributions will

                                     19


be applied to the MIT Pledge at their market value at the time the shares 
become publicly traded or otherwise monetized in a commercial transaction and 
are free from restriction as to sale by MIT.  At March 31, 1998, the Company
would have to fund additional cash and/or property that would have to
be valued at a total of approximately $750,000 by December 1998, in order
for the Senior Professorship to become permanent.

     In June 1997, the Company agreed to provide one of its investee 
companies with a $450,000 revolving line of credit, of which $110,000 had 
been used through March 31, 1998.  The purpose of this line of credit, which 
will be secured by accounts receivable, is to provide for seasonal cash flow. 
To the extent that this line of credit is utilized, the Company will also 
receive warrants to purchase common stock.

     In December 1997, the Company signed a Demand Promissory Note for a
$4,000,000 line of credit with J.P. Morgan collateralized by the Company's 
U.S. Treasury obligations.  In March 1998 the line of credit was increased 
to $6,000,000.  As of December 31, 1997, the Company had borrowed $4,000,000
against the line of credit.  From December 31, 1997 to January 2, 1998, the 
rate on the line of credit was prime (8.5 percent).  From January 2, 1998 to 
April 2, 1998, the interest rate on the line of credit was libor plus 
1.5 (7.3125 percent). In March 1998, the Company paid down $2,500,000; in 
April 1998, the Company paid the remaining balance. 

     On April 9, 1998 the Company announced that it had received under 
section 851(e) of the Code certification from the Securities and Exchange 
Commission for 1997, and accordingly, the Company's Board of Directors declared
a one-time cash dividend of $0.75 per share (for a total of $8,019,728) to
meet one of the Company's requirements for qualification for Sub-Chapter M tax
treatment in 1998.  The dividend will be paid on May 12, 1998.   There can be
no assurance that the Company will qualify for Sub-Chapter M tax treatment in
1998 or subsequent periods.

         
NOTE 7.  SUBSEQUENT EVENTS
                                                 
     On April 15, 1998, the Company announced that the Board of Directors had
approved the repurchase of up to 700,000 shares of Company stock in the open
market.  As of May 8, 1998, the Company had repurchased a total of 27,500 
shares for a total of $83,875 or an average of $3.05 per share.

     Also on April 15, 1998, the Company announced the close of the sale of
PureSpeech, Inc. to Voice Control Systems, Inc. (Nasdaq National Market 
Symbol: "VCSI").  In this transaction, the Company is receiving 268,239 Voice 
Control Systems common shares, including 56,171 shares purchased for $82,953 
through exercise of warrants on April 2, 1998.  Ten percent of the shares of 
VCSI owned by the Company are subject to escrow for one year to cover 
breaches of representations or warranties by PureSpeech.  All of the 
Company's VCSI shares are restricted under Rule 144, but the Company has a 
demand registration right.

                                  20

Item 2. Management's Discussion and Analysis of Financial Condition 
        and Results of Operations

     The Company accounts for its operations under Generally Accepted 
Accounting Principles for investment companies.  On this basis, the principal 
measure of its financial performance is captioned "Net (decrease) increase in 
net assets from operations," which is the sum of three elements.  The first 
element is "Net operating loss," which is the difference between the Company's
income from interest, dividends, and fees and its operating expenses, net of 
applicable income tax benefit.  The second element is "Net realized (loss) gain
on investments," which is the difference between the proceeds received from
dispositions of portfolio securities and their stated cost, net of applicable 
income tax provisions (benefits).  These two elements are combined in the 
Company's financial statements and reported as "Net realized (loss) income."  
The  third element, "Net increase (decrease) in unrealized appreciation on
investments," is the net change in the fair value of the Company's investment
portfolio, net of increase (decrease) in deferred income taxes that would
become payable if the unrealized appreciation were realized through the sale
or other disposition of the investment portfolio.

     "Net realized (loss) gain on investments" and "Net increase (decrease)
in unrealized appreciation on investments" are directly related.  When a 
security is sold to realize a (loss) gain, net unrealized appreciation 
(increases) decreases and net realized gain (decreases) increases. 

Financial Condition

     The Company's total assets and net assets were, respectively, 
$36,167,658 and $33,651,403 at March 31, 1998, compared to  $39,273,784 and 
$33,654,934 at December 31, 1997.  Net asset value per share was $3.15 
at March 31, 1998 and December 31, 1997.  The Company's shares outstanding 
were 10,692,971 as of March 31, 1998 and December 31, 1997.

     The Company's financial condition is dependent on the success of its
investments.  The Company has invested a substantial portion of its assets 
in private development stage or start-up companies.  These private businesses
tend to be thinly capitalized, unproven, small companies that lack management 
depth or have no history of operations.  At March 31, 1998, approximately 45 
percent of the Company's $36.2 million in total assets consisted of investments 
at fair value in private businesses, of which net unrealized appreciation was 
approximately $5.2 million before taxes.  At December 31, 1997, approximately 
34 percent of the Company's $39.3 million in total assets consisted of 
investments at fair value in private businesses, of which net unrealized
appreciation was approximately $2.5 million.
     
                                    21                                   

     A summary of the Company's investment portfolio is as follows:

<TABLE>
<S>                                   <C>             <C>
                                      March 31, 1998  December 31, 1997

Investments, at cost                    $ 27,854,793       $ 30,500,498
Unrealized appreciation                    7,821,705          8,158,732
                                         -----------        -----------

Investments, at fair value              $ 35,676,498       $ 38,659,230
                                         ===========        ===========
</TABLE>

The accumulated unrealized appreciation on investments net of deferred 
taxes is $5,812,764 at March 31, 1998, versus $5,340,834 at December 31, 1997.

     Following an initial investment in a private company, the Company may 
make additional investments in such investee in order to: (1) increase its 
ownership percentage; (2) to exercise warrants or options that were acquired in
a prior financing; (3) to preserve the Company's proportionate ownership in a 
subsequent financing; or (4) attempt to preserve or enhance the value of the 
Company's investment.  Such additional investments are referred to as 
"follow-on" investments.  There can be no assurance that the Company will make
follow-on investments or have sufficient funds to make additional investments. 
The failure to make such follow-on investments could jeopardize the viability 
of the investee company and the Company's investment or could result in a 
missed opportunity for the Company to participate to a greater extent in an
investee's successful operations.  The Company attempts to maintain adequate
liquid capital to make follow-on investments in its private investee 
portfolio companies.  The Company may elect not to make a follow-on investment
either because it does not want to increase its concentration of risk or
because it prefers other opportunities, even though the follow-on
investment opportunity appears attractive.

     The following table is a summary of the cash investments made by the
Company in its private placement portfolio during the three months ended 
March 31, 1998:

<TABLE>
     <S>                                <C>
     Follow-on Investments:                   Amount

     MultiTarget, Inc.                   $    51,802
                                         -----------
          Sub-total                      $    51,802

     Loans:
     BioSupplyNet, Inc.                  $    60,000
     NBX Corporation                          10,000
                                         -----------
          Sub-total                      $    70,000
                                         -----------
     Total                               $   121,802
                                         ===========
</TABLE>
                                     22
  
Results of Operations

Investment Income and Expenses:

     The Company's principal objective is to achieve capital appreciation. 
Therefore, a significant portion of the investment portfolio is structured to
maximize the potential for capital appreciation and provides little or no 
current yield in the form of dividends or interest.  The Company does earn
interest income from fixed-income securities, including U.S. Government 
Obligations.  The amount of interest income earned varies based upon the 
average balance of the Company's fixed-income portfolio and the average yield 
on this portfolio.  
  
     The Company had interest income from fixed-income securities of $192,291 
and $136,287 for the three months ended March 31, 1998 and 1997, respectively.  
The increase is due to the additional funds the Company had available for 
investment in fixed-income securities in 1998 as a result of the funds borrowed 
against the JP Morgan line of credit. 

     Operating expenses were $371,450 and $720,599 for three months ended 
March 31, 1998 and 1997, respectively.  The decrease is primarily due to: the 
reversal of $198,763 for the Company's profit-sharing plan accrual made in the 
fourth quarter of 1997, a decrease in salaries as a result of reduced staff and 
a decrease in overall expenses as a result of the Company's effort to cut 
expenses.  The decreases were offset by the interest expense on the funds drawn
on the JP Morgan line of credit.  Most of the Company's operating expenses are 
related to employee and director compensation, office and rent expenses and 
consulting and professional fees (primarily legal and accounting fees).
  
     Net operating losses before taxes were $160,879 and $573,443 for the 
three months ended March 31, 1998 and 1997, respectively.

     For a discussion of the tax benefit and provision in the first quarter of
1998, see Note 5 of Notes to Financial Statements.  

     The Company has in the past relied, and continues to rely to a large 
extent, upon proceeds from sales of investments, rather than investment income, 
to defray a significant portion of its operating expenses.  Because such 
sales cannot be predicted with certainty, the Company attempts to maintain 
adequate working capital to provide for fiscal periods when there are no such 
sales. 

Realized Gains and Losses on Sales of Portfolio Securities:

     During the three months ended March 31, 1998 and 1997, the Company sold
various investments, realizing net gains of $78,661 and $623,108, respectively.

                                    23

Unrealized Appreciation and Depreciation of Portfolio Securities:

     Net unrealized appreciation on investments before taxes decreased by 
$337,027 during the three months ended March 31, 1998, from $8,158,732 to 
$7,821,705, primarily as a result of  increased valuations on NeuroMetrix, 
Inc.; PureSpeech,Inc.; Energy Research Corporation and Fuisz Technologies 
Corporation.  These gains were offset primarily by decreased valuations in 
Nanophase Technologies Corporation, Princeton Video Image, Inc. and MedLogic 
Global Corporation.

     Net unrealized appreciation on investments before taxes decreased 
$2,604,225 during the three months ended March 31, 1997 from $6,667,589 to 
$4,063,364, owing primarily to decreased valuations on Harber Brothers 
Productions, Inc. and PureSpeech, Inc.

Liquidity and Capital Resources

     The Company reported total cash, receivables and marketable securities 
(the primary measure of liquidity) at March 31, 1998 of $18,247,303 (net of 
$1,500,000 drawn from the JP Morgan line of credit) versus $21,693,067 (net 
of $4,000,000 drawn from the J.P. Morgan line of credit) at December 31, 1997.  
Included in marketable securities are the Company's holdings in Nanophase 
Technologies Corporation of $3,051,400 and Princeton Video Image, Inc. of 
$966,536.  Both holdings are subject to lock-up agreements and are valued at 
March 31, 1998 at discounts from market value: a 22 percent discount in the 
case of Nanophase Technologies Corporation and a 21 percent discount in the 
case of Princeton Video Image, Inc.  

     As of March 31, 1998, the Company had a $6,000,000 line of credit in 
place with J.P. Morgan, of which the Company had borrowed $1,500,000.  
Management believes that its cash, receivables and marketable securities 
provide the Company with sufficient liquidity for its operations. 

     On May 12, 1998, the Company will pay out a one-time cash dividend of 
$0.75 per share for a total of $8,019,728, to meet one of the requirements 
for qualification for Sub-Chapter M tax treatment in 1998.

Recent Developments

     The Company intends to elect to be treated as a RIC for federal income 
tax purposes for 1998 and to try to continue to maintain that status.  (See 
Item 1.  Financial Statements.)  As a qualifying RIC, if the Company 
distributes to stockholders annually in a timely manner at least 90% of its 
"investment company taxable income," as defined in the Code (i.e., net 
investment income, including accrued original issue discount, and net short-
term capital gains) (the "90% Distribution Requirement"), it will not be 
subject to federal income tax on the portion of its investment company 
taxable income and net capital gains (net long-term capital gain in excess 
of net short-term capital loss) distributed to stockholders. In addition, if
the Company distributes in a timely manner 98% of its capital gain net 
income for each one-year period ending on December 31, and distributes 98% 
of its net ordinary income for each calendar year (as well as any income not
distributed in prior years), 

                                 24

it will not be subject to the 4% nondeductible federal excise tax imposed
with respect to certain undistributed income of RICs.  The Company
generally will endeavor to distribute to stockholders all of its investment 
company taxable income and its net capital gain, if any, for each taxable
year so that such Company will not incur income and excise taxes on its 
earnings.

     In order to qualify as a RIC for federal income tax purposes, the 
Company must, among other things:  (a) continue to qualify as a BDC under the 
1940 Act, (b) derive in each taxable year at least 90% of its gross income 
from dividends, interest, payments with respect to securities loans, gains from 
the sale of stock or securities, or other income derived with respect to its
business of investing in such stock or securities (the "90% Income Test"); and
(c) adequately diversify its holdings pursuant to detailed rules set forth in 
section 851 of the Code.

     If the Company acquires or is deemed to have acquired debt obligations 
that were issued originally at a discount or that otherwise are treated under 
applicable tax rules as having original issue discount, the Company will be 
required to include in income each year a portion of the original issue 
discount that accrues over the life of the obligation regardless of whether 
cash representing such income is received in the same taxable year and to 
make distributions accordingly.

     Although it does not presently expect to do so, the Company is authorized 
to borrow funds and to sell assets in order to satisfy distribution 
requirements. However, under the 1940 Act, the Company is not permitted to make 
distributions to stockholders while the Company's debt obligations and other 
senior securities are outstanding unless certain "asset coverage" tests are 
met.  Moreover, the Company's ability to dispose of assets to meet its 
distribution requirements may be limited by other requirements relating to its 
status as a RIC, including the diversification requirements.  If the Company 
disposes of assets in order to meet distribution requirements, the  Company 
may make such dispositions at times which, from an investment standpoint, 
are not advantageous.

     If the Company fails to satisfy the 90% Distribution Requirement or 
otherwise fails to qualify as a RIC in any taxable year, it will be subject to 
tax in such year on all of its taxable income, regardless of whether the 
Company makes any distributions to its stockholders.  In addition, in that case,
all of the Company's distributions to its stockholders will be characterized as 
ordinary income (to the extent of the Company's current and accumulated 
earnings and profits).  In contrast, as is explained below, if the Company 
qualifies as a RIC, a portion ofits distributions may be characterized as 
long-term capital gain in the hands of stockholders.

     Other than distributions properly designated as "capital gain dividends" 
as is described below, dividends to stockholders of the investment company 
taxable income of the Company will be taxable as ordinary income to 
stockholders to the extent of the Company's current or accumulated earnings and 
profits, whether paid in cash or reinvested in additional shares.  
Distributions of the Company's net capital gain properly designated by the 
Company as "capital gain dividends" will be taxable to stockholders as a 
long-term capital gain regardless of the stockholder's holding
period for his or her shares.  Distributions in excess of the Company's 

                                   25

earnings and profits will first reduce the adjusted tax basis of the 
stockholder's shares and, after the adjusted basis is reduced to zero, will 
constitute capital gains to the stockholder.  For a summary of the tax rates 
applicable to capital gains, including capital gains dividends, see 
discussion below.

     To the extent that the Company retains any net capital gain, it may 
designate such retained gain as "deemed distributions" and pay a tax thereon 
for the benefit of its stockholders.  In that event, the stockholders will be 
required to report their share of retained net capital gain on their tax 
returns as if it had been distributed to them and report a credit, or claim a 
refund, for the tax paid thereon by the Company.  The amount of the deemed 
distribution net of such tax will be added to the stockholder's cost basis
for his or her shares.  Since the Company expects to pay tax on net capital 
gain at its regular corporate capital gain tax rate, and since that rate is 
in excess of the maximum rate currently payable by individuals on net capital 
gain, the amount of tax that individual stockholders will be treated as 
having paid will exceed the amount of tax that such stockholders
would be required to pay on net capital gain.

     Stockholders who are not subject to federal income tax or tax on capital
gains should be able to file a Form 990T or an income tax return on the 
appropriate form that allows them to recover the taxes paid on their behalf.

     Any dividend declared by the Company in October, November, or December of 
any calendar year, payable to stockholders of record on a specified date in 
such a month and actually paid during January of the following year, will be 
treated as if it had been received by the stockholders on December 31 of the 
year in which the dividend was declared.

     Investors should be careful to consider the tax implications of buying 
shares just prior to a distribution.  Even if the price of the shares includes 
the amount of the forthcoming distribution, the stockholder generally will be 
taxed upon receipt of the distribution and will not be entitled to offset the 
distribution against the tax basis in his or her shares.

     A stockholder may recognize taxable gain or loss if he or she sells or
exchanges his or her shares.  Any gain arising from (or, in the case of
distributions in excess of earnings and profits, treated as arising from) the 
sale or exchange of shares generally will be a capital gain or loss.  This 
capital gain or loss normally will be treated as a long-term capital gain or 
loss if the stockholder has held his or her shares for more than one year; 
otherwise, it will be classified as short-term capital gain or loss.  However, 
any capital loss arising from the sale or exchange of shares held for six 
months or less will be treated as a long-term capital loss to the extent of 
the amount of capital gain dividends received with respect to such shares 
and, for this purpose, the special rules of Section 246(c)(3) and (4) of 
the Code generally apply in determining the holding period of shares.  
It is unclear how any such long-term capital loss offsets capital gains 
taxable at different rates.  All or a portion of any loss realized upon 
a taxable disposition of shares of the Company may be disallowed if other 
shares of the Company are purchased within 30 days before or after the
disposition. 

                                      26

     In general, net capital gain (the excess of net long-term capital 
gain over net short-term capital loss) of non-corporate taxpayers is 
currently subject to a maximum federal income tax rate of 28% (subject to 
reduction in many situations) while other income may be taxed at rates as 
high as 39.6%.  Capital gains derived from the disposition of assets held 
for more than 18 months generally are subject to federal income tax at 
the rate of 20%.  Corporate taxpayers are currently subject to federal 
income tax on net capital gain at the maximum 35% rate also applied to 
ordinary income.  Tax rates imposed by states and local jurisdictions on
capital gain and ordinary income may differ.

     The Company may be required to withhold U.S. federal income tax
at the rate of 31% of all taxable dividends and distributions payable to 
stockholders who fail to provide the Company with their correct taxpayer 
identification number or to make required certifications, or regarding 
whom the Company has been notified by the IRS that they are subject to 
backup withholding.  Backup withholding is not an additional tax, and 
any amounts withheld may be credited against a stockholder's U.S. federal
income tax liability.

     Federal withholding taxes at a 30% rate (or a lesser treaty rate) 
may apply to distributions to stockholders that are nonresident aliens 
or foreign partnerships, trusts, or corporations.  Foreign investors 
should consult their tax advisors with respect to the possible U.S. 
federal, state, and local tax consequences and foreign tax consequences
of an investment in the Company. 

     The Company will send to each of its stockholders, as promptly as 
possible after the end of each fiscal year, a notice detailing, on a 
per share and per distribution basis, the amounts includible in such 
stockholder's taxable income for such year as ordinary income and as 
long-term capital gain.  In addition, the federal tax status of each 
year's distributions generally will be reported to the IRS.  
Distributions may also be subject to additional state, local, and 
foreign taxes depending on a stockholder's particular situation. The 
Company's ordinary income dividends to its corporate shareholders may,
if certain conditions are met, qualify for the dividends received 
deduction to the extent that the Company has received qualifying 
dividend income during the taxable year; capital gain dividends
distributed by the Company are not eligible for the dividends 
received deduction. 

     If necessary for liquidity purposes, in lieu of distributing its 
taxable net capital gains, the Company may retain such net capital 
gains and elect to be deemed to have made a distribution of the gains, 
or part thereof, to the shareholders under the "designated undistributed 
capital gain" rules of section 852(b)(3) of the Code.  In such a case, 
the Company would have to pay a 35 percent corporate level income tax on 
such "designated undistributed capital gain," but it would not have to
distribute the excess of the retained "designated undistributed capital 
gain" over the amount of tax thereon in order to maintain its RIC status.

     On May 12, 1998, the Company will distribute its cumulative E&P 
through December 31, 1997 for a total of approximately $8.0 million.  
As of March 31, 1998, the Company believes that it has sufficient current 
assets to make such distribution without jeopardizing its ability to pay its 
operating expenses as they may become due.

                                    27

Risks

     There are significant risks inherent in the Company's venture 
capital business.  The Company has invested a substantial portion 
of its assets in private development stage or start-up companies.  
These private businesses tend to be thinly capitalized, unproven, 
small companies that lack management depth and have not attained 
profitability or have no history of operations.  Because of the speculative
nature and the lack of a public market for these investments, there is
significantly greater risk of loss than is the case with traditional 
investment securities.  The Company expects that some of its venture 
capital investments will be a complete loss or will be unprofitable 
and that some will appear to be likely to become successful but never 
realize their potential.  The Company has been risk seeking rather 
than risk averse in its approach to venture capital and other investments.
Neither the Company's investments nor an investment in the Company is
intended to constitute a balanced investment program.  The Company has 
in the past relied and continues to rely to a large extent upon proceeds
from sales of investments rather than investment income to defray a 
significant portion of its operating expenses.


Risks Relating to the Year 2000 Issue

     The Company believes that the Year 2000 problem is not material to 
the Company.  Many computer software systems in use today cannot recognize 
the Year 2000 and may revert to 1900 or some other date because of the way 
in which dates were encoded and calculated.  The Company could be adversely 
affected if its computer system or those of its service providers do not 
properly process and calculate date-related information and data on and 
after January 1, 2000.  The Company has been actively working on necessary
changes to its computer systems to prepare for the Year 2000 and intends 
to obtain reasonable assurances from its service providers that they are 
taking comparable steps with respect to their computer systems.  However,
the steps the Company is taking and intends to take does not guarantee 
complete success or eliminate the possibility that interaction with 
outside computer systems may have an adverse impact on the Company.


Forward-Looking Statements

     The information contained herein contains certain forward-looking
statements.  These statements include the plans and objectives of 
management for future operations and financial objectives, portfolio
growth and availability of funds.  These forward-looking statements 
are subject to the inherent uncertainties in predicting future results
and conditions.  Certain factors that could cause actual results and 
conditions to differ materially from those projected in these 
forward-looking statements are set forth herein.  Other factors 
that could cause actual results to differ materially include the
uncertainties of economic, competitive and market conditions, and
future business decisions, all of which are difficult or impossible 
to predict accurately and many of which are beyond the control of 
the Company.  Although the Company believes that the assumptions
underlying the forward-looking statements included herein are 
reasonable, any of the assumptions could be inaccurate and therefore, 

                                 28

there can be no assurance that the forward-looking statements included
or incorporated by reference herein will prove to be accurate.  
Therefore, the inclusion of such information should not be
regarded as a representation by the Company or any other person 
that the objectives and plans of the Company will be achieved.


Item 3.  Quantitative and Qualitative Disclosures About Market Risk

     Not Applicable

                                   29


PART II.  OTHER INFORMATION

Item 1.  Legal Proceedings
         Not Applicable

Item 2.  Changes in Securities and Use of Proceeds
         Not Applicable

Item 3.  Defaults Upon Senior Securities
         Not Applicable

Item 4.  Submission of Matters to a Vote of Security Holders
         Not Applicable

Item 5.  Other Information
         Not Applicable

Item 6.  Exhibits and Reports on Form 8-K

         3.1(a)Restated Certificate of Incorporation of the Company, as
               amended, incorporated by reference to Exhibit 3.1(a) to 
               the Company's Form 10-K for the year ended December 31, 1995.

         3.1(b)Restated By-laws of the Company, incorporated by reference to
               Exhibit 3.1(b) to the Company's Form 10K for the
               year ended December 31, 1995.

         4.1   Specimen Certificate of Common Stock, incorporated by
               reference to Exhibit 4 to Company's Registration Statement on 
               Form N-2 filed October 29, 1992.

        10.16* Demand Promissory Note - Line of Credit, Statement of Purpose
               for an Extension of Credit Secured by Margin Stock by and 
               among Harris & Harris Group, Inc. And J.P. Morgan.

        11.0*  Computation of per share earnings.  See Statement of Operations.

        27.0*  Financial Data Schedule.
       
        (b)    The Company did not file any reports on Form 8-K during the first
               quarter of 1998.
                         
                                    30

EXHIBIT INDEX

Item Number (of Item 601 of Regulation S-K)

27. Financial Data Schedule

                                    31

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, 
the Registrant has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                   Harris & Harris Group, Inc.


                                   By: /s/ Rachel M. Pernia 
                                   -------------------------
                                   Rachel M. Pernia, Vice President
                                   Treasurer, Controller and Principal
                                   Accounting Officer


Date: May 15, 1998
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 6
       
<S>                                <C>
<PERIOD TYPE>                      3-MOS
<FISCAL-YEAR-END>                  DEC-31-1998
<PERIOD-END>                       MAR-31-1998
<INVESTMENTS-AT-COST>              $27,854,793 
<INVESTMENTS-AT-VALUE>              35,676,498
<RECEIVABLES>                                0
<ASSETS-OTHER>                         491,160
<OTHER-ITEMS-ASSETS>                         0
<TOTAL-ASSETS>                      36,167,658
<PAYABLE-FOR-SECURITIES>                     0
<SENIOR-LONG-TERM-DEBT>                      0
<OTHER-ITEMS-LIABILITIES>            2,516,255
<TOTAL-LIABILITIES>                  2,516,255
<SENIOR-EQUITY>                              0
<PAID-IN-CAPITAL-COMMON>            16,178,979
<SHARES-COMMON-STOCK>               10,692,971
<SHARES-COMMON-PRIOR>               10,692,971
<ACCUMULATED-NII-CURRENT>           11,552,730
<OVERDISTRIBUTION-NII>                       0
<ACCUMULATED-NET-GAINS>                      0
<OVERDISTRIBUTION-GAINS>                     0
<ACCUM-APPREC-OR-DEPREC>             5,812,764
<NET-ASSETS>                        33,651,403
<DIVIDEND-INCOME>                            0
<INTEREST-INCOME>                      203,223
<OTHER-INCOME>                           7,348
<EXPENSES-NET>                         371,450
<NET-INVESTMENT-INCOME>               (526,591)
<REALIZED-GAINS-CURRENT>                78,661
<APPREC-INCREASE-CURRENT>             (337,027)
<NET-CHANGE-FROM-OPS>                   (3,531)
<EQUALIZATION>                               0
<DISTRIBUTIONS-OF-INCOME>                    0
<DISTRIBUTIONS-OF-GAINS>                     0
<DISTRIBUTIONS-OTHER>                        0
<NUMBER-OF-SHARES-SOLD>                      0
<NUMBER-OF-SHARES-REDEEMED>                  0
<SHARES-REINVESTED>                          0
<NET-CHANGE-IN-ASSETS>                  (3,531)
<ACCUMULATED-NII-PRIOR>             12,028,191
<ACCUMULATED-GAINS-PRIOR>                    0
<OVERDISTRIB-NII-PRIOR>                      0
<OVERDIST-NET-GAINS-PRIOR>                   0
<GROSS-ADVISORY-FEES>                        0
<INTEREST-EXPENSE>                      73,415
<GROSS-EXPENSE>                              0
<AVERAGE-NET-ASSETS>                         0
<PER-SHARE-NAV-BEGIN>                     3.15
<PER-SHARE-NII>                           (.04)
<PER-SHARE-GAIN-APPREC>                    .04
<PER-SHARE-DIVIDEND>                         0
<PER-SHARE-DISTRIBUTIONS>                    0
<RETURNS-OF-CAPITAL>                         0
<PER-SHARE-NAV-END>                       3.15
<EXPENSE-RATIO>                              0
<AVG-DEBT-OUTSTANDING>               2,750,000
<AVG-DEBT-PER-SHARE>                      0.26

        

</TABLE>


DEMAND PROMISSORY NOTE -- LINE OF CREDIT


                                                     Date: March 26, 1998

U.S. $6,000,000.00


     FOR VALUE RECEIVED, Harris & Harris Group, Inc. (the "Borrower")promises
to pay to the order of MORGAN GUARANTY TRUST COMPANY OF NEW YORK (the "Bank"),
ON DEMAND at its office at 60 Wall Street, New York, New York 10260-0060,
U.S.A., for the account of its Lending Office (as hereinafter defined), in
lawful money of the United States of America in same day funds (or in such
funds as may from time to time become customary for the settlement of
international transactions in U.S. dollars), the lesser of (i) U.S.
$6,000,000.00 or (ii) the then-outstanding principal amount of each loan (the
"Loan" or "Loans") made by the Bank from time to time to the Borrower
hereunder.  The Borrower shall pay interest on the unpaid principal amount of
each Loan until maturity on the dates and at a rate per annum as hereinafter
set forth.  As used herein, "Lending Office" means, (i) with regard to Loans
bearing interest based on the Prime Rate (as hereinafter defined)
(collectively, "Domestic Loans"), the office of the Bank located at 60 Wall
Street, New York, New York or such other office as the Bank may designate, and
(ii) with regard to Loans bearing interest based on the Eurodollar Rate (as
hereinafter defined) (collectively, "Eurodollar Loans"), the Nassau (Bahamas)
office of the Bank or such other office as the Bank may designate.

     Interest based on the Prime Rate shall be computed on the basis of a year
of 365 days (or 366 days in a leap year) and paid for actual days elapsed
(including the first day but excluding the last day).  Interest based on the
Eurodollar Rate shall be computed on the basis of a year of 360 days and paid
for the actual number of days elapsed (including the first day but excluding
the last day).

     Each Eurodollar Loan shall bear interest at a rate per annum (the
"Eurodollar Rate") equal to the Adjusted Eurodollar Rate (as hereinafter
defined) plus 1.500% (the Eurodollar Margin"), payable on the last day of the
Interest Period applicable thereto and, if such Interest Period is longer than
three months, at intervals of three months after the first day thereof.  The
"Adjusted Eurodollar Rate" applicable to any Interest Period (as hereinafter
defined) means a rate per annum equal to the quotient obtained (rounded
upwards, if necessary, to the next higher 1/100 of 1%) by dividing (i) the
applicable London Interbank Offered Rate by (ii) 1.00 minus the Eurodollar
Reserve Percentage.  The "London Interbank Offered Rate" applicable to any
Interest Period means the rate per annum at which deposits in U.S. dollars are
offered to the Bank in the London interbank market at approximately 11:00 a.m.
(London time) two business days prior to the first day of such Interest Period
in an amount approximately equal to the principal amount of the Loan to which
such Interest Period applies and for the period of time comparable to such
Interest Period.  The "Eurodollar Reserve Percentage" means for any day that
percentage (expressed as a decimal) which is in effect on such day, as
prescribed by the Board of Governors of the Federal Reserve System (or any
successor) for determining the maximum reserve requirement for a member bank
of the Federal Reserve System in New York City with deposits exceeding five
billion dollars in respect of "Eurocurrency liabilities" (or in respect of any
other category of liabilities which includes deposits by reference to which
the interest rate on the Loans is determined or any category of extensions of
credit or other assets which includes loans by a non-United States office of
the Bank to United States residents).  The Adjusted Eurodollar Rate shall be
adjusted automatically on and as of the effective date of any change in the
Eurodollar Reserve Percentage.  As used herein, the term "Interest Period"
means the period beginning on the date of each Eurodollar Loan and ending on
the numerically corresponding day in the calendar month One or Three months
after such date; provided, that if an Interest Period would otherwise end on a
day which is not a business day it shall be extended to the next succeeding
business day unless such business day falls in the next calendar month, in
which case the Interest Period shall end on the next preceding business day;
provided, further, that if the Bank shall not have received written notice to
the contrary from the Borrower at least five business days prior to the end of
an Interest Period the Borrower shall be deemed to have requested to select an
Interest Period with a duration equal to that then ending.  As used herein,
the term "business day" means any day on which dealings in U.S. dollar
deposits are carried on in the London interbank market and on which commercial
banks are open for domestic and foreign exchange business in London and New
York City.  Notice by the Bank to the Borrower of the rate of interest so
determined shall be binding and conclusive upon the Borrower in the absence of
manifest error.

     Each Domestic Loan shall bear interest payable on the last day of each
month at a rate per annum for each day equal to the rate of interest publicly
announced by the Bank in New York City from time to time as its Prime Rate
(the "Prime Rate") for such day, plus 0.000%.

     The Borrower shall pay interest on the unpaid principal amount of each
Loan after the maturity thereof and, to the extent permitted by law, on
accrued and unpaid interest until paid at a rate per annum equal to the sum of
2% plus the Prime Rate.

     If after the date of this Note any applicable rule, executive order,
decree, regulation or interpretation is amended, modified, enacted or
promulgated by any government or governmental authority so as to (i) change
the basis of taxation of payments to the Bank or the Lending Office of the
Bank extending a Eurodollar Loan (the "Eurodollar Lending Office") in respect
to the principal of and interest on any Eurodollar Loan (except for changes in
the rate of taxation on the overall net income of the Bank by the United
States of America or the Eurodollar Lending Office of the Bank by the
jurisdiction in which such Lending Office is located), or (ii) impose, modify
or deem applicable any reserve, special deposit or similar requirement against
any of the assets of, deposits with or for the account of, or credit extended
by the Bank's Eurodollar Lending Office, or (iii) impose on the Bank (or its
Eurodollar Lending Office) or the London interbank market any other conditions
affecting any Loan, the Loans or this Note, and the result of any of the
foregoing is to increase the cost to the Bank (or its Eurodollar Lending
Office) of agreeing to make or making, funding or maintaining any Loan
evidenced by this Note or would have the effect of reducing the rate of return
on the capital of the Bank or any entity controlling the Bank (its "Parent")
as a consequence of agreeing to make any Loan, or to reduce the amount of any
sum receivable by the Bank (or its Eurodollar Lending Office) on this Note,
then the Borrower shall pay to the Bank or its Parent upon demand such amount
as will compensate the Bank or its Parent for such additional cost or
reduction in return.  A certificate of the Bank setting forth the basis for
the determination of any amount necessary to compensate the Bank or its Parent
as aforesaid shall be conclusive as to the determination of such amount in the
absence of manifest error.

     If, after the date of this Notice, the introduction of, or any change in,
any applicable law, rule or regulation or in the interpretation or
administration thereof by any governmental authority charged with the
interpretation or administration thereof or compliance by the Bank (or its
Eurodollar Lending Office) with any request or directive (whether or not
having the force of law) of any such authority shall make it unlawful or
impossible for the Bank (or its Eurodollar Lending Office) to make, maintain
or fund its Eurodollar Loans, the Bank forthwith shall so notify the Borrower. 
Upon receipt of such notice, the Borrower shall prepay in full the then
outstanding principal amount of each Eurodollar Loan, together with accrued
interest thereon, either (a) on the last day of the Interest Period applicable
thereto if the Bank may lawfully continue to maintain and fund such Loan to
such day or (b) immediately if the Bank may not lawfully continue to fund and
maintain such Loan to such day.  

     Eurodollar Loans may not be repaid at the Borrower's option on a date
other than the last day of an Interest Period.  If, however, the Borrower
makes any payment of principal of any Eurodollar Loan or any day other than
the last day of the Interest Period applicable thereto, the Borrower shall
reimburse the Bank on demand for any loss or expense incurred by it as a
result of the timing of such payment, including (without limitation) any loss
incurred in obtaining, liquidating or employing deposits from third parties,
provided that the Bank shall have delivered to the Borrower a certificate as
to the amount of such loss, which certificate shall be conclusive in the
absence of manifest error.

     Domestic Loans may be prepaid at any time without penalty or premium.

     The Borrower hereby waives diligence, presentment, demand, protest and
notice of any kind whatsoever.  The non-exercise by the Bank of its rights
hereunder in any particular instance shall not constitute a waiver of any
right in any subsequent instance.

     The holder of this Note shall, and is hereby authorized by the Borrower
to, endorse on the schedule forming a part hereof appropriate notations
evidencing the date and the amount of each Loan made by the Bank, the date and
amount of each payment of principal, whether such Loan is a Domestic or
Eurodollar Loan and, in the case of Eurodollar Loans, the Eurodollar Rate
applicable thereto.

     If this Note is not paid in full when due the Borrower agrees to pay all
costs and expenses of collection including reasonable attorney's fees.  The
Borrower shall reimburse the Bank on demand for any transfer taxes,
documentary taxes, assessments or charges that are imposed at any time on or
in connection with this Note, any renewal hereof, the debt evidenced hereby or
any advance made hereunder and shall indemnify the Bank against liability for
any such tax (including any interest and penalties).

     To secure payment of this Note, the Borrower hereby transfers, pledges,
gives a security interest in and delivers to the Bank all present and future
contents of the Borrower's

         USA Treasurers held in Morgan Custody Account C88659

, all proceeds and products thereof, accessions thereto and substitutions
therefor (the  "Collateral").

     Upon the nonpayment of any amount when due hereunder, the holder shall
have the rights and remedies provided in the Uniform Commercial Code in force
in New York at the date of execution of this Note and in addition to, in
substitution for, in modification of, or in conjunction with those rights and
remedies, the holder or its agents may, in its discretion, sell, assign and
deliver all or any part of the Collateral at any broker's board or at public
or private sale without notice or advertisement, and bid and become purchasers
at any public sale or at any broker's board, and, if notice to the Borrower is
required by law, give written notice to the Borrower five days prior to the
date of public sale of the Collateral or prior to the date after which private
sale of the Collateral will be made by mailing such notice to the address
designated by the Borrower with the Borrower's signature below.  The Borrower
agrees that the proceeds of the disposition of the collateral may be applied
by the holder to the satisfaction of the liabilities of the Borrower to the
holder in any order of preference which the holder, in its sole discretion,
chooses, and that the excess, if any, shall be returned to the Borrower, which
shall continue liable to the holder for any deficiency remaining with interest
thereon.  The waiver or remedying of any default shall not operate as a waiver
of the default remedies or any other prior or subsequent default.

     The undersigned, if more than one, shall be jointly and severally liable
hereunder and the term "Borrower" shall mean the undersigned or any one or
more of them and their heirs, executors, administrators, successors and
assigns.

     THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAW
OF THE STATE OF NEW YORK.  THE BORROWER HEREBY SUBMITS TO THE NONEXCLUSIVE
JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF
NEW YORK AND OF ANY NEW YORK STATE COURT SITTING IN NEW YORK CITY FOR PURPOSES
OF ALL LEGAL PROCEEDINGS ARISING OUT OF OR RELATING TO THIS NOTE OR ANY
AGREEMENT RECEIVED BY THE BANK IN CONNECTION HEREWITH.  THE BORROWER
IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION
WHICH THE BORROWER MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY
SUCH PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH PROCEEDING
BROUGHT IN SUCH A COURT HAS BEEN IN AN INCONVENIENT FORUM.  THE BORROWER
HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE OR ANY AGREEMENT RECEIVED
BY THE BANK IN CONNECTION HEREWITH.

By executing and delivering this Note to the Bank, the Borrower is deemed to
have agreed to be bound by the Terms and Conditions of Advised Line of Credit
and any changes or revisions made thereto pursuant to paragraph 7 thereof.


SIGNATURE:

/s/Mel P. Melsheimer
- ---------------------
Mel P. Melsheimer
President & COO
Harris & Harris Group, Inc.


Address: One Rockefeller Plaza
         Suite 1430
         New York, NY 10020

<PAGE>
              BOARD OF GOVERNORS OF THE FEDERAL RESERVE SYSTEM

    Statement of Purpose for an Extension of Credit Secured by Margin Stock

                 Morgan Guaranty Trust Company of New York
                ____________________________________________
                               Name of Bank

                       (Federal Reserve Form U-1)

   This form is required by law (15 U.S.C. Sections 78g and 78w; 12 CFR 221)

Instructions

1.   This form must be completed when a bank extends credit in excess of
     $100,000 secured directly or indirectly, in whole or in part, by any 
     margin stock.

2.   The term "margin stock" is defined in Regulation U (12 CFR 221) and
     includes, principally: (1) stocks that are registered on a national 
     securities exchange or that are on the Federal Reserve Board's List of 
     Marginable OTC Stocks; (2) debt securities (bonds) that are convertible 
     into margin stocks; (3) any over-the-counter security designated as 
     qualified for trading in the National Market System under a designation 
     plan approved by the Securities and Exchange Commission (NMS security); 
     and (4) shares of mutual funds, unless 95 per cent of the assets of the 
     fund are continuously invested in U.S. government, agency, state, or 
     municipal obligations.

3.   Please print or type (if space is inadequate, attach separate sheet).

Part 1 To be completed by borrower(s).

1.   What is the amount of the credit being extended?    $6,000,000 = Six
     Million Dollars

2.   Will any part of this credit be used to purchase or carry margin stock?  
     Yes ____ No _X_

If the answer is "no", describe the specific purpose of the credit.  WORKING
CAPITAL

I (we) have read this form and certify that to the best of my (our) knowledge
and belief the information given in true, accurate, and complete, and that 
the margin stock and any other securities collateralizing this credit are
authentic, genuine, unaltered, and not stolen, forged, or counterfeit.

Signed:

/s/Mel P. Melsheimer
- --------------------
Mel P. Melsheimer   3/26/98

Harris & Harris Group, Inc.

                     This form should not be signed in blank.

          A borrower who falsely certifies the purpose of a credit on this 
         form or otherwise willfully or intentionally evades the provisions
           of Regulation U will also violate Federal Reserve Regulation X
                     "Borrower of Securities Credit."


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission